scientific program - World Allergy Organization
scientific program - World Allergy Organization
scientific program - World Allergy Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MONDAY<br />
64<br />
MONDAY, 8 SEPTEMBER - continued<br />
WAO Congress–XVIII ICACI Final Program<br />
P-2-25 Clinical effects of salmeterol on patients with bronchial<br />
asthma: assessment of respiratory function and QOL<br />
Tochigi T1 , Minowa K1 , Egashira Y2 1 2 Kamoike Seikyo Clinic, Kagoshima-shi, Japan, Kyusyu<br />
University of Nursing and Social Welfare, Tamana-shi, Japan<br />
P-2-26 Short term therapy of budesonide reduces reactivity to<br />
inhaled adenosine 5'-monophosphate<br />
Gaszczyk G1 , Latos T1 , Bokiej J1 1National Research Institute of Mother and Child, Karpacz,<br />
Dolnoslaskie, Poland<br />
P-2-27 Secretary of Health of Rio de Janeiro/Brazil: survey on<br />
pediatricians’ knowledge of inhalation therapy for<br />
asthmatic children<br />
Galvao MG1 , Santos MS1 , Ibiapina AI2 , Cunha AC2 1Secretaria Municipal de Saúde do Rio de Janeiro, Rio de Janeiro,<br />
Brazil, 2Universidade Federal do Rio de Janeiro, Rio de Janeiro,<br />
Brazil<br />
P-2-28 Comparison of traditional Chinese-Japanese herbal<br />
medicine bakumondo-to with emedastine difumarate on<br />
asthmatic patients with increased cough sensitivity<br />
Watanabe NW1 , Gang CG1 , Fukuda TF1 1Dokkyo University School of Medicine, Shimotsuga-gun,<br />
Tochigi-ken, Japan<br />
P-2-29 Inhibition of airway hyperresponsiveness and inflammation<br />
by a nonenzymatic antioxidant-lipoic acid in a mouse<br />
model of asthma<br />
Cho YS1 , Kim YY1 , Lee HR2 , Lee EY1 , Yoo B1 , Moon HB1 , Lee<br />
J1 1Division of <strong>Allergy</strong> and Rheumatology, Asan Medical Center,<br />
Seoul, Republic of Korea, 2Asan Institute for Life Sciences, Seoul,<br />
Republic of Korea<br />
P-2-30 Comparison of salmeterol inhaler with tulobuterol tape by<br />
QOL questionnaire, Asthma Health Questionnaire-34,<br />
Japan<br />
Komase Y1 , Saitoh H1 , Nakagawa T2 1St. Marianna University, Yokohama-city Hospital, Yokohama,<br />
Kanagawa, Japan, 2St. Marianna University, Kawasaki,<br />
Kanagawa, Japan<br />
P-2-31 New holding chamber improves inhaled dose of HFA<br />
salbutamol<br />
Donnell D1 13M Pharmaceuticals, Loughborough, Leics, UK<br />
P-2-32 A cost comparison of asthma control in children using a<br />
staged dose reduction design of fluticasone (F) or<br />
beclomethasone extrafine aerosol (Q)<br />
Price DA1 1Aberdeen University, Aberdeen, UK<br />
P-2-33 Dose-response comparison of beclomethasone extrafine<br />
aerosol (Q) from two devices in patients with moderate<br />
asthma<br />
Gross G1 , Donnell D2 1University of Texas Southwestern Medical School, Dallas, TX,<br />
USA, 23M Pharmaceuticals, Loughborough, Leics, UK<br />
POSTER SESSIONS<br />
P-2-34 A dose reduction comparison of beclomethasone extrafine<br />
aerosol (Q) and fluticasone (F) in children with<br />
symptomatic asthma<br />
Price DA1 , Van Aalderen WMC2 , Price JF3 1 2 Aberdeen University, Aberdeen, UK, Emma’s Children’s<br />
Hospital, University of Amsterdam, Amsterdam, Netherlands,<br />
3King’s College Hospital, London, UK<br />
P-2-35 Compliance with the treatment in asthmatic school-age<br />
children<br />
Volonaki HM1 , Volonakis KM1 , Papaioannou DI1 , Volonakis<br />
MK1 1Agia Sofia Children’s Hospital, Athens, Greece<br />
P-2-36 IL-2 intravenous application as one of the methods of<br />
steroid-saving therapy of the patients with severe steroiddependent<br />
asthma<br />
Tofimov VI1 , Shaporova NL1 , Shiri ZA1 , Ses TP2 1Saint-Petersburg Pavlov’s State Medical University, Saint-<br />
Petersburg, Russian Federation, 2Saint-Petersburg Institute of<br />
Pulmonology, Saint-Petersburg, Russian Federation<br />
P-2-37 Asthma quality of life and systemic safety of<br />
beclomethasone extrafine aerosol (Q) and fluticasone (F) in<br />
children<br />
Van Aalderen WMC1 , Hugen CAC2 , Tiddens HAWM3 1Emma Children’s Hospital, University of Amsterdam,<br />
Amsterdam, Netherlands, 2University Lung Centre, Dekkerswald,<br />
Netherlands, 3Erasmus Medical Centre/Sophia, Erasmus<br />
University, Rotterdam, Netherlands<br />
P-2-38 Sparing effect of coenzyme Q10, α-tocopherol and ascorbic<br />
acid on the consumption of corticosteroids in allergic<br />
asthmatics<br />
Gazdik F1 , Gazdikova K1 , Jahnova E1 , Pijak MR1 1Institute of Preventive and Clinical Medicine, Bratislava, Slovak<br />
Republic<br />
P-2-39 SURF Study: real-life effectiveness of budesonide/<br />
formoterol (B/F) adjustable maintenance dosing<br />
Michilis A1 , Peché RVJ2 , Verbraecken JA3 , Vandenhoven G4 ,<br />
Wollaert L5 , Duquenne V5 1 2 CUB Erasme, Brussels, Belgium, CHU Vesale, Montigny-Le-<br />
Tilleul, Belgium, 3University Hospital Antwerp, Antwerp,<br />
Belgium, 4SA AstraZeneca NV, Brussels, Belgium, 5Belgium P-2-40 Treatment with Serevent and Flixotide under pressurized<br />
aerosols form (MDI) on a lot of children from Galatzi<br />
Ierima GA1 1Emergency Hospital for Children, Galatzi, Romania<br />
P-2-41 Immediate and long time clinical effect and safety after<br />
high-dose of intravenous immunoglobulin therapy in<br />
patients with severe asthma<br />
Klos K1 , Kruszewski J1 1Department of Infectious Diseases and Allergology, Warsaw,<br />
Poland<br />
P-2-42 Four-week administration of inhaled budesonide prevents<br />
exercise-induced asthma in adolescents with asthma<br />
Yagi K 1 , Onda T 2 , Obata T 3<br />
1 Division of Pediatrics, Yagi Clinic, Yokosuka, Kanagawa, Japan,<br />
2 Onda Clinic, Kawasaki, Kanagawa, Japan, 3 Obata Pediatric<br />
Clinic, Kawasaki, Kanagawa, Japan